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Abstract
The exact role of hypoxia in tumor biology remains controversial because there is no 
conclusive evident on its effect on tumors. There is concern that tumor hypoxia is one 
of the causes of chemoresistance in cancer cells. Recently, erythropoietin receptors have 
been found in human breast cancer cells indicating that recombinant human erythropoietin 
(rHuEPO) treatment of cancer-related anemia can influence the functions of the cells. 
Bovine lactoferrin (bLF) was also shown to have antiproliferative effects on cancer 
cells. The aim of this study was to determine the in vitro effects of rHuEPO, bLF and 
Doxorubicin (DOX) on a canine mammary gland tumor cell line, CMT-stylo cells, under 
hypoxic condition. The cells were treated with bLF, rHuEPO, DOX  rHuEPO and DOX 
and bLF, rHuEPO combinations. These treated cells were subjected to MTT assay. The 
results showed that hypoxia lowered the proliferation rate of the CMT-stylo cells while 
combination treatments showed improved killing. Flow cytometry analysis showed that 
DOX had cytotoxic while bLF had antiproliferative effects on the CMT-stylo cells.
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